The Trump administration is preparing to announce a deal this week with Eli Lilly and Novo Nordisk to lower the price of ...

The Trump administration is negotiating a deal with weight-loss drugmakers Eli Lilly and Novo Nordisk that would allow the ...

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...

The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk that would cut the price of obesity drugs to $149 per month in some cases and extend coverage to certain ...

Piedmont Macon is hosting a free Diabetes Conference with education sessions and resources for patients and caregivers.

An Institute for Clinical and Economic Review report concluded that the GLP-1 drugs tirzepatide and semaglutide (Ozempic, ...

Since her 2021 diabetes diagnosis, Stephanie Guignard, a nurse practitioner, has made it her mission to educate people on how ...

People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack or stroke, University of Pittsburgh researchers reported.

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...